Rusthoven, J: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy

Jane E. Latz, James J. Rusthoven, Mats O. Karlsson, Atalanta Ghosh, Robert D. Johnson

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2006

Language:

english

File:

PDF, 385 KB

english, 2006

52

A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy

Jane E Latz, Mats O Karlsson, James J Rusthoven, Atalanta Ghosh, Robert D Johnson

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2006

Language:

english

File:

PDF, 565 KB

english, 2006

53

The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy

J. J. Rusthoven, David Osoba, Charles A. Butts, Louise Yelle, Helen Findlay, Andrew Grenville

Journal:

Supportive Care in Cancer

Year:

1998

Language:

english

File:

PDF, 88 KB

english, 1998

54

Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy

Adam Raben, Kyle E. Rusthoven, Abrihup Sarkar, Andrew Glick, Bruce Benge, Dayee Jacobs, David Raben

Journal:

Year:

2009

Language:

english

File:

PDF, 146 KB

english, 2009

55

Toxicity Assessment of Pelvic Intensity-Modulated Radiotherapy With Hypofractionated Simultaneous Integrated Boost to Prostate for Intermediate- and High-Risk Prostate Cancer

Robert McCammon, Kyle E. Rusthoven, Brian Kavanagh, Sherri Newell, Francis Newman, David Raben

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2009

Language:

english

File:

PDF, 282 KB

english, 2009

56

Effect of Radiation Techniques in Treatment of Oropharynx Cancer

Kyle E. Rusthoven, David Raben, Ari Ballonoff, Madeleine Kane, John I. Song, Changhu Chen

Journal:

The Laryngoscope

Year:

2008

Language:

english

File:

PDF, 178 KB

english, 2008

57

Outcomes of Patients with N3 Neck Nodes Treated with Chemoradiation

Ari Ballonoff, David Raben, Kyle E. Rusthoven, Michael Bassetti, Madeleine Kane, John I. Song, Changhu Chen

Journal:

The Laryngoscope

Year:

2008

Language:

english

File:

PDF, 193 KB

english, 2008

58

Dietary therapy in two patients with a mild form of sulphite oxidase deficiency. Evidence for clinical and biological improvement

G. Touati, E. Rusthoven, E. Depondt, C. Dorche, M. Duran, B. Heron, D. Rabier, M. Russo, J. M. Saudubray

Journal:

Journal of Inherited Metabolic Disease

Year:

2000

Language:

english

File:

PDF, 98 KB

english, 2000

59

Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group

Ian Quirt, Audley Bodurtha, Reinhard Lohmann, James Rusthoven, Karl Belanger, Vincent Young, Nancy Wainman, William Steward, Elizabeth Eisenhauer

Journal:

Investigational New Drugs

Year:

2002

Language:

english

File:

PDF, 69 KB

english, 2002

60

The rostralpars distalisof the pituitary gland of the freshwater and marine alewife (Alosa pseudoharengus)

H. Cook, J. J. Rusthoven, N. J. Vogelzang

Journal:

Cell and Tissue Research

Year:

1973

Language:

english

File:

PDF, 3.70 MB

english, 1973

61

Characterization of culture-induced cytotoxicity from human peripheral lymphocyte subpopulations

James J. Rusthoven, David Osoba

Journal:

Cellular Immunology

Year:

1986

Language:

english

File:

PDF, 560 KB

english, 1986

62

Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-β in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody

H.W. Hirte, D.A. Clark, G. O'Connell, J. Rusthoven, J. Mazurka

Journal:

Cellular Immunology

Year:

1992

Language:

english

File:

PDF, 633 KB

english, 1992

63

Simultaneous randomization to multiple dose levels and an active comparator as a means of determining the minimal effective dose of an investigational agent

Joseph L. Pater, Laurie Smaldone, Benny Zee, Janis Goodlow, James Rusthoven, Marcel Rozencweig

Journal:

Controlled Clinical Trials

Year:

1991

Language:

english

File:

PDF, 77 KB

english, 1991

64

Survival and Patterns of Relapse in Patients With Oral Tongue Cancer

Kyle E. Rusthoven, David Raben, John I. Song, Madeleine Kane, Taghrid A. Altoos, Changhu Chen

Journal:

Journal of Oral and Maxillofacial Surgery

Year:

2010

Language:

english

File:

PDF, 477 KB

english, 2010

65

Pemetrexed safety and dosing strategy

Clet Niyikiza, Axel-R Hanauske, James J. Rusthoven, A.Hilary Calvert, Robert Allen, Paolo Paoletti, Paul A. Bunn Jr

Journal:

Seminars in Oncology

Year:

2002

Language:

english

File:

PDF, 74 KB

english, 2002

66

Clinical isolation and characterization of aminoglycoside-resistant small colony variants of enterobacter aerogenes

James J. Rusthoven, Theresa A. Davies, Stephen A. Lerner

Journal:

The American Journal of Medicine

Year:

1979

Language:

english

File:

PDF, 809 KB

english, 1979

67

The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma

Journal:

European Journal of Cancer

Year:

1998

Language:

english

File:

PDF, 74 KB

english, 1998

68

Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy With Temozolomide Chemotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme

Changhu Chen, Denise Damek, Laurie E. Gaspar, Allen Waziri, Kevin Lillehei, B.K. Kleinschmidt-DeMasters, Monica Robischon, Kelly Stuhr, Kyle E. Rusthoven, Brian D. Kavanagh

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2011

Language:

english

File:

PDF, 429 KB

english, 2011

69

Assessment of Organ Motion in Postoperative Endometrial and Cervical Cancer Patients Treated With Intensity-Modulated Radiation Therapy

Eleanor E.R. Harris, Kujtim Latifi, Chad Rusthoven, Ken Javedan, Kenneth Forster

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2011

Language:

english

File:

PDF, 183 KB

english, 2011

70

Phase II trial of MTA (AlimtaTM) and cisplatin in patients with advanced Non-Small Cell Lung Cancer (NSCLC)

Shepherd, F.A, Arnold, A, Neville, A, Dancey, J, Rusthoven, J, Fisher, B, Eisenhauer, E

Journal:

Year:

2000

Language:

english

File:

PDF, 113 KB

english, 2000

71

Pemetrexed (ALIMTA), a novel multitargeted antifolate agent, is active alone and in combination in thoracic tumors

Adjei, A.A, Calvert, A.H, Hanauske, A, Rusthoven, J

Journal:

Year:

2000

Language:

english

File:

PDF, 271 KB

english, 2000

72

ALIMTA (TM) (pemetrexed, LY231514, MTA) in non-small cell lung cancer

Clarke, S.J, Abratt, R.P, Postmus, P.P, Rusthoven, J, Manegold, C

Journal:

Year:

2000

Language:

english

File:

PDF, 111 KB

english, 2000

73

Establishing baseline quality of life data in patients with mesothelioma as part of the randomized ALIMTA™ trial

Gralla, R.J, Hollen, P.J, Liepa, A.M, Hartsock, K.J, Rusthoven, J.R

Journal:

Year:

2000

Language:

english

File:

PDF, 119 KB

english, 2000

74

P-514 Can baseline quality of life parameters predict survival and other efficacy outcomes in malignant pleural mesothelioma?: Results from a 448-patient phase III trial

Gralla, R.J., Symanowski, J.T., Liepa, A.M., Boyer, M.J., Ruffie, P., Moro-Sibilot, D., Hollen, P.J., Rusthoven, J.J., Vogelzang, N.J.

Journal:

Year:

2003

Language:

english

File:

PDF, 193 KB

english, 2003

75

P-401 Evaluating improvement in patient-reported dyspnea and pulmonary function tests (PFTs) in patients with malignant pleural mesothelioma (MPM): An analysis as part of the 448-patient randomized pemetrexed + cisplatin versus cisplatin trial

Gralla, R., Symanowski, J., Boyer, M., Paoletti, P., Rusthoven, J., Manegold, C., Lianes, P., Liepa, A., Vogelzang, N.

Journal:

Year:

2005

Language:

english

File:

PDF, 298 KB

english, 2005

76

P-422 Use of forced vital capacity (FVC) measurement for the clinical management of malignant pleural mesothelioma (MPM): Observations from the pemetrexed plus cisplatin versus cisplatin study

Pistolesi, M., Symanowski, J., Rusthoven, J., Paoletti, P., McAndrews, P., Vogenlzang, N.

Journal:

Year:

2005

Language:

english

File:

PDF, 149 KB

english, 2005

77

P-431 Updated multiple regression analysis of prognostic variables for survival in malignant pleural mesothelioma (MPM): Observations from a phase III study of pemetrexed plus cisplatin versus cisplatin and evolution of the regression model

Symanowski, J., Rusthoven, J., Vogelzang, N.

Journal:

Year:

2005

Language:

english

File:

PDF, 327 KB

english, 2005

78

P-435 Long-term survival update from the randomized phase III study of pemetrexed plus cisplatin vs cisplatin in patients with malignant pleural mesothelioma (MPM)

Vogelzang, N., Symanowski, J., Rusthoven, J., Manegold, C., Boyer, M., Nguyen, B., Paoletti, P.

Journal:

Year:

2005

Language:

english

File:

PDF, 323 KB

english, 2005

79

905 Documenting symptom palliation with chemotherapy using the LCSS-Meso: Results from the randomized trial of pemetrexed plus cisplatin vs cisplatin alone in patients with malignant pleural mesothelloma

R. Gralla, P. Hollen, A. Liepa, J. Symanowski, J. Rusthoven, M. Boyer, J. Jassem, N. Vogelzang

Journal:

European Journal of Cancer Supplements

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

80

A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma

H.W. Hirte, D.A. Clark, J. Mazurka, G. O'Connell, J. Rusthoven

Journal:

International Journal of Gynecology & Obstetrics

Year:

1992

Language:

english

File:

PDF, 292 KB

english, 1992

81

A phase I study of GM-CSF, cyclophosphamide (CP), and escalating doses of carboplatin (CBDCA) in chemotherapy-Naïve patients with ovarian cancer

J. Rusthoven, L. Levin, E. Eisenhauer, J. Carmichael, J. Mazurka, P. Bryson, G. O'connell, H. Hirte

Journal:

Gynecologic Oncology

Year:

1991

Language:

english

File:

PDF, 328 KB

english, 1991

82

A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma

H.W. Hirte, D.A. Clark, J. Mazurka, G. O'Connell, J. Rusthoven

Journal:

Gynecologic Oncology

Year:

1992

Language:

english

File:

PDF, 370 KB

english, 1992

83

O54. Survival and patterns of relapse in patients with oral tongue cancer

Rusthoven, K., Raben, D., Song, J., Kane, M., Altoos, T., Chen, C.

Journal:

Oral Oncology Supplement

Year:

2009

Language:

english

File:

PDF, 37 KB

english, 2009

84

The Risk of Varicella-Zoster Infections in Different Patient Populations: A Critical Review

James J. Rusthoven

Journal:

Transfusion Medicine Reviews

Year:

1994

Language:

english

File:

PDF, 2.00 MB

english, 1994

85

Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint

James J Rusthoven, Elisabeth G.E de Vries, David C Dale, Martine Piccart, John Glaspy, Anne Hamilton

Journal:

International Journal of Antimicrobial Agents

Year:

1997

Language:

english

File:

PDF, 339 KB

english, 1997

86

High Incidence of Lung Cancer After Non–Muscle-Invasive Transitional Cell Carcinoma of the Bladder: Implications for Screening Trials

Kyle E. Rusthoven, Thomas W. Flaig, David Raben, Brian D. Kavanagh

Journal:

Clinical Lung Cancer

Year:

2008

Language:

english

File:

PDF, 130 KB

english, 2008

87

Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis

Rusthoven, Kyle E., Hammerman, Susan F., Kavanagh, Brian D., Birtwhistle, Michael J., Stares, Mark, Camidge, D. Ross

Journal:

Acta Oncologica

Year:

2009

Language:

english

File:

PDF, 101 KB

english, 2009

88

Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema

Carlson, J. A., Nooruddin, Z., Rusthoven, C., Elias, A., Borges, V. F., Diamond, J. R., Kavanagh, B., Kabos, P.

Journal:

Year:

2014

Language:

english

File:

PDF, 168 KB

english, 2014

89

The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study

Rusthoven, Chad G., Carlson, Julie A., Waxweiler, Timothy V., Raben, David, Dewitt, Peter E., Crawford, E. David, Maroni, Paul D., Kavanagh, Brian D.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2014

Language:

english

File:

PDF, 718 KB

english, 2014

90

Stereotactic body radiation therapy (SBRT) for liver metastases: A clinical review

Rusthoven, Chad G., Lauro, Christine F., Kavanagh, Brian D., Schefter, Tracey E.

Journal:

Seminars in Colon and Rectal Surgery

Year:

2014

Language:

english

File:

PDF, 398 KB

english, 2014

91

Nonrhabdomyosarcoma Soft Tissue Sarcomas in Children: A Surveillance, Epidemiology, and End Results Analysis

Waxweiler, T.V., Proper, M.S., Rusthoven, C., Liu, A.K.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2013

Language:

english

File:

PDF, 46 KB

english, 2013

92

3DCRT and IMRT Improve Local Control Versus Opposed Laterals in Early-Stage Squamous Cell Carcinoma of the Larynx

Zhao, S., Strom, T., Caudell, J., Rusthoven, C., Shridhar, R., Trotti, A., Rao, N.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Year:

2013

Language:

english

File:

PDF, 65 KB

english, 2013

93

The prognostic significance of Gleason scores in metastatic prostate cancer

Rusthoven, Chad G., Carlson, Julie A., Waxweiler, Timothy V., Yeh, Norman, Raben, David, Flaig, Thomas W., Kavanagh, Brian D.

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2014

Language:

english

File:

PDF, 552 KB

english, 2014

94

Clinical significance of natural killer cell cytotoxicity: Need for proper data analysis in the design of clinical studies

Rusthoven, James J.

Journal:

European Journal of Cancer and Clinical Oncology

Year:

1985

Language:

english

File:

PDF, 780 KB

english, 1985

95

Biological response modifiers and infectious diseases: Actual and potential therapeutic agents

Rusthoven, James J.

Journal:

International Journal of Antimicrobial Agents

Year:

1994

Language:

english

File:

PDF, 2.38 MB

english, 1994

96

Health-related quality of life of patients with malignant pleural mesothelioma treated with pemetrexed disodium

Gralla, R., Hollen, P., Liepa, A., Rusthoven, J.

Journal:

European Journal of Cancer

Year:

2001

Language:

english

File:

PDF, 165 KB

english, 2001

97

Sarcomas of the Aorta: A Systematic Review and Pooled Analysis of Published Reports

Rusthoven, Chad G., Liu, Arthur K., Bui, Marilyn M., Schefter, Tracey E., Elias, Anthony D., Lu, Xian, Gonzalez, Ricardo J.

Journal:

Annals of Vascular Surgery

Year:

2014

Language:

english

File:

PDF, 652 KB

english, 2014

98

Dexamethasone (DEX) improves the efficacy of granisetron (GRAN) in the first 24 hours following high dose cisplatin (HDCP) chemotherapy

Latreille, J., Stewart, D., Laberge, F., Hoskins, P., Rusthoven, J., McMurtrie, E., Warr, D., Yelle, L., Walde, D., Shepherd, F., Dhaliwal, H., Findlay, B., Mee, D., Pater, J., Zee, B., Johnston, D.

Journal:

European Journal of Cancer

Year:

1993

Language:

english

File:

PDF, 174 KB

english, 1993

99

Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC)

Rusthoven, J., Eisenhauer, E., Butts, C., Gregg, R., Dancey, J., Fisher, B., Iglesias, J.

Journal:

European Journal of Cancer

Year:

1997

Language:

english

File:

PDF, 261 KB

english, 1997

100

1204 Preventing nausea and vomiting during days 2–7 following high dose cisplatin chemotherapy (HDCP)

Johnston, D., Latreille, J., Laberge, F., Stewart, D., Rusthoven, J., Findlay, B., Ernst, S., Williams, C.K.O., Hoskins, P., Yelle, L., McMurtrie, E., Dhahwal, H., Nishimura, L., Pater, J., Zee, B.

Journal:

European Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 142 KB

english, 1995